Skip to main content

Diabetes & Weight Loss News

Another diabetes drug that helps people lose weight?
What this dramatic movement in obesity therapy means for patients in Europe.
Our main takeaways from this conference: new apps, startling statistics, and more!
Will it be the first US city to have warning labels for sugary drinks?
Current trial results show that obese patients using Contrave are about 41% less likely to experience any major heart event (e.g. heart attack, strokes, or heart-related...
What other fast food chains are already on board?
Major A1c improvements, weight loss, and no injections!
Twitter summary: FDA approves Novo Nordisk’s chronic weight management drug Saxenda, another option to help treat #obesity On December 23, the FDA approved Novo Nordisk’...
Three things to know about the new US Surgeon General Dr. Vivek Murthy, who has his sights set on tackling obesity.
The two trillion dollar problem – a new report provides a groundbreaking look at the worldwide cost of obesity.
What can obesity learn from seatbelts, airbags, and tobacco? Our interview with Robert Wood Johnson Foundation’s Dr. Marks.
Twitter summary: Contrave launched in the US w/ weight support program + savings/loyalty programs offer new option for patients Two healthcare companies, Orexigen and...
Twitter summary: AACE/ACE publish position statement on obesity w/ 4 step plan: screen, examine, evaluate, treat/prevent! Kudos 4 focus on proactive diagnosis The...
Twitter summary: @omadahealth announces $950K in funding to bring #diabetes prevention program to low-income communities On September 17, Omada Health announced that it...
A controversial and groundbreaking ballot vote next month – how the Bay Area hopes to tackle diabetes and obesity.
Twitter summary: After huge anticipation for this innovative drug combination, Novo Nordisk’s Xultophy received approval in Europe for #T2D, 1 st ever basal insulin/GLP-...
Twitter summary: CDC releases state-by-state obesity data, several states see increases in adult obesity rates – childhood obesity rates level off The Center for Disease...
Twitter summary: FDA approves Contrave weight management drug, with potential future use in #T2D On September 10, the FDA announced the approval of Orexigen’s weight...
Twitter summary: Exciting positive vote for #liraglutide #emdac on possible new therapy for #obesity! Plus, our favorite open public hearing yet. Yesterday on September...
The provocative documentary Fed Up , which offers an unflinching look at the real causes and challenges of America’s obesity epidemic, is currently playing in select...

Pages